The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis
Menon, I.S.
Acta Universitatis Carolinae. Medica. Monographia 52: 181-184
1972
ISSN/ISBN: 0567-8250 PMID: 4669820 Document Number: 53889
Document emailed within 1 workday
Related Documents
Wu, J.-d.; Guan, H.; Wang, S.-h.; Liu, C.-w.; Jin, Y.-f.; Liu, B.; Ye, W.; Zeng, R. 2005: Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator Zhonghua Yi Xue Za Zhi 85(7): 491-492Schwarz, T.; Langenberg, K.; Oettler, W.; Halbritter, K.; Beyer, J.; Siegert, G.; Gehrisch, S.; Schroeder, H.E.; Schellong, S.M. 2002: Deep vein and isolated calf muscle vein thrombosis following long-haul flights: pilot study Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 13(8): 755-757
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Jørgensen, M.; Mortensen, J.Z.; Madsen, A.G.; Thorsen, S.; Jacobsen, B. 1983: A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis Ugeskrift for Laeger 145(30): 2302-2303
Sprengers, E.D.; Akkerman, J.W.; Jansen, B.G. 1986: Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood Thrombosis and Haemostasis 55(3): 325-329
Berkowitz, S.D. 1995: Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium Orthopedics 18 Suppl: 18-20
Bornstein, N.M.; Norris, J.W. 1988: Deep vein thrombosis after ischemic stroke: rationale for a therapeutic trial Archives of Physical Medicine and Rehabilitation 69(11): 955-958
Zielinsky, A.; Hirsh, J. 1981: Prevention of deep vein thrombosis and pulmonary thromboembolism Medicina 41(4): 485-498
Le Quesne, L.P. 1974: The prevention of deep vein thrombosis and pulmonary embolism South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 12(3): 119-126
Prandoni, P.; Mosena, L. 2001: Home treatment and secondary prevention of deep vein thrombosis Haematologica 86(11 Suppl. 2): 49-53
Gutman, H.; Zelikovski, A.; Reiss, R. 1982: Prevention of deep vein thrombosis and pulmonary emboli in surgical patients Harefuah 103(11): 312-313
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Hubens, A.; Peeters, R. 1976: The case for more active prevention of deep-vein thrombosis after major surgery Acta Chirurgica Belgica 75(4): 402-415
Kettunen, K.; Poikolainen, E.; Karjalainen, P.; Oksala, I.; Alhava, E.; Rehnberg, V.; Huttunen, H.; Mattila, M. 1974: Prevention of postoperative deep vein thrombosis with small doses of heparin Duodecim; Laaketieteellinen Aikakauskirja 90(11): 834-838
Prerovský, I.; Niederle, P.; Simonová, J.; Kapitola, J. 1988: Deep vein thrombosis and its prevention in patients with acute myocardial infarction Cor et Vasa 30(5): 345-351
Hirmerova, J.; Seidlerova, J.; Subrt, I. 2013: Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors International Angiology: a Journal of the International Union of Angiology 32(4): 410-416
Ahmed, A. 2005: Prevention of deep vein thrombosis and pulmonary embolism in the perioperative period: a review Jpma. Journal of the Pakistan Medical Association 55(8): 343-347
Francis, C.W.; Pellegrini, V.D.; Totterman, S.; Boyd, A.D.; Marder, V.J.; Liebert, K.M.; Stulberg, B.N.; Ayers, D.C.; Rosenberg, A.; Kessler, C.; Johanson, N.A. 1997: Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin Journal of Bone and Joint Surgery. American Volume 79(9): 1365-1372
Emerson, P.A.; Teather, D.; Handley, A.J. 1974: The application of decision theory to the prevention of deep vein thrombosis following myocardial infarction Quarterly Journal of Medicine 43(171): 389-398
Higo, K.; Karasawa, A.; Kubo, K. 1991: Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)- ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate in a canine model of femoral thrombosis Arzneimittel-Forschung 41(12): 1251-1255